日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

利用肿瘤靶向RNA沉默药物在小鼠和人体中抑制HIF2活性和肿瘤生长

Yuanqing Ma ,Allison Joyce # ,Olivia Brandenburg # ,Faeze Saatchi # ,Christina Stevens ,Vanina Toffessi Tcheuyap ,Alana Christie ,Quyen N Do ,Oluwatomilade Fatunde ,Alyssa Macchiaroli ,So C Wong ,Layton Woolford ,Qurratulain Yousuf ,Jeffrey Miyata ,Deyssy Carrillo ,Oreoluwa Onabolu ,Tiffani McKenzie ,Akhilesh Mishra ,Tanner Hardy ,Wei He ,Daniel Li ,Alexander Ivanishev ,Qing Zhang ,Ivan Pedrosa ,Payal Kapur ,Thomas Schluep ,Steven B Kanner ,James Hamilton ,James Brugarolas

HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma

透明细胞肾细胞癌患者使用 PT2385(一种首创的 HIF-2 抑制剂)治疗时 HIF-2 复合物解离、靶标抑制和获得性耐药性

Kevin D Courtney #, Yuanqing Ma #, Alberto Diaz de Leon #, Alana Christie, Zhiqun Xie, Layton Woolford, Nirmish Singla, Allison Joyce, Haley Hill, Ananth J Madhuranthakam, Qing Yuan, Yin Xi, Yue Zhang, Jenny Chang, Oluwatomilade Fatunde, Yull Arriaga, Arthur E Frankel, Sanjeeva Kalva, Song Zhang, Ti